Medtronic (MDT) Says New Data Shows Benefits of Its Insulin Pumps for People with Type 2 Diabetes
Tweet Send to a Friend
Medtronic plc (NYSE: MDT) today announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
